Loading...
TrendSpott

TrendSpott

TrendSpott
 
 
G1 Therapeutics
2.57
-1.15%
 
Recommendation
GTHX G1 Therapeutics
  Login
 
 
Last Price
 
Change
 
2.57
 
-1.15%
 
 

 
Sentiment
 
  Login to display
 
 

3.34

5.46

8.74

8

 
 
1m
3m
6m
1y
 

Summary

  Login to display G1 Therapeutics (GTHX) recommendation from the last 90 days from financial news and social media.
 

Rewards

Rewards

 Upgraded on attractively valued

 

Risk Analysis

Risk Analysis

 Analysts lowered price target

 
 

Risk Level

 
TrendSpott
 

G1 Therapeutics (GTHX) has High Risk Level

Click here to check what is your level of risk

 

Analysts Opinion

Click on the category for more information
 
 
Earnings ×
 

Earnings

2.67
 

TrendSpott

Reported a weak earnings

TrendSpott

Earnings decline YoY

TrendSpott

Above analyst estimates

 
 
Rating ×
 

Rating

3.00
 

TrendSpott

Upgraded on attractively valued

 
Momentum ×
 

Momentum

2.50
 

TrendSpott

Price value has negative momentum

 
Activity ×
 

Activity

3.30
 
 
Future ×
 

Future

1.00
 

TrendSpott

Analysts lowered price target

 
 

Analysts Opinion

Analysts opinion is negative but has improved from the past 3 months

 

Street Consensus

Buy
Opinion
Trend
Score
Potential
Score
 
36%
50%
0%
0%
 
On Track
On Track
On Track
 

Street Opinion 

Street view is unimpressive and have negative views on the near-term outlook

 
Events Rating
 
Very Bullish
Bullish
Neutral
Bearish
Very Bearish
 
Positive vs Negative
 
36%
45%
Positive
Negative
8 out of 22
events present
10 out of 22
events present
 

 
Events Calendar
Click for more information
 
February
S
M
T
W
T
F
S
March
S
M
T
W
T
F
S
 
Highlights
Last
Modify
Closing
Price
%
Change
 
Strong Earnings
3 Weeks Ago
3.67
+1.38%
 
Weak Earnings
2 Month Ago
3.67
+6.07%
 
Price Target Lowered
2 Month Ago
3.34
-53.16%
 
Upgrade
2 Month Ago
7.46
+11.18%
 
Investors Activity
3 Month Ago
5.99
+5.09%
 
Top Headlines

g1 therapeutics (gthx) reports q4 loss tops revenue estimates. g1 therapeutics (gthx) came out with a quarterly loss of $0.73 per share versus the zacks consensus estimate of a loss of $0.85. this compares to loss of $0.94 per share a

Wed Mar 1, 2023

Earnings
Earnings

g1 therapeutics (gthx) may report negative earnings: know the trend ahead of q4 release. g1 therapeutics (gthx) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter end

Wed Feb 15, 2023

Earnings

nasdaq rises 1.5%. g1 therapeutics shares plummet. United States stocks traded higher midway through trading with the nasdaq composite gaining around 1.5% on monday. the dow traded up 0.96% to 34193.83 while the nasdaq rose 1.52% to 11896.75. the s&.p

Mon Feb 13, 2023

Momentum

g1 therapeutics pt lowered to $5 at wedbush.

Mon Feb 13, 2023

Potential

g1 therapeutics to discontinue cancer drug trial shares plunge 40%. g1 therapeutics inc said on monday it would terminate its cancer therapy study as the placebo outperformed the drug in its late-stage trial sending its shares plunging 40% befor

Mon Feb 13, 2023

Momentum

g1 therapeutics to discontinue phase 3 preserve 1 trial. (rttnews) - oncology company g1 therapeutics inc. (gthx) announced monday topline results from its pivotal phase 3 preserve 1 trial showing that the trial achieved its co-primary endpoints

Mon Feb 13, 2023

Activity

: g1 therapeutics upgraded to neutral from underweight at j.p. morgan. this is a real-time headline. these are breaking news delivered the minute it happens delivered ticker-tape style. visit www.marketwatch.com or the e page for more information about th

Mon Jan 30, 2023

Rating
Rating

g1 therapeutics (gthx) presents at the 41st annual j.p. morgan healthcare conference -- slideshow.

Thu Jan 12, 2023

Activity

g1 therapeutics posts early mid-stage results for bladder cancer therapy.

Wed Jan 4, 2023

Activity

 
 
 
TrendSpott

Get all the pieces of the puzzle on important data activity before the major news sources break the story and find out what happening right now and what could happen in the future

FIND US ON

TrendSpott on Twitter TrendSpott on YouTube TrendSpott on stocktwits TrendSpott Rss
 

Receive our daily GTHX alerts

Enter your email to receive daily alerts

 
Home

Leading Gainers

Upgrades

Downgrades

Top Leaders

 
Categories

Ipo's

Dividend

Option Activity

Insiders Activity

Institutional Holdings

 
Tags

New Products

FDA Approvals

Agreements

Financial Reports

 
About Us

Log In

Sign Up

Contact Us

Terms of use

Privacy Policy

 
 

Disclaimer: The Score performance whether actual or indicated by historical tests of strategies, is no guarantee of future performance or success. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The Readiness Indicators, Sentiment Indicators and total score are calculated by the retroactive application of a model constructed on the basis of historical data and based on assumptions integral to the model which may or may not be testable and are subject to losses. Active trading is generally not appropriate for someone of limited resources, limited invesment or trading experience, or low-risk tolerance. Your capital may be at risk.

Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by TrendSpott including any of their affiliates ("TS").

This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.

 
TrendSpott

TrendSpott

Get the pulse of the market

 
TrendSpott

TrendSpott

GTHX G1 Therapeutics

Last Price
2.57
Change
-1.15%
Recommendation
  Login to display
 

Summary

  Login to display G1 Therapeutics (GTHX) recommendation from the last 90 days from financial news and social media.

 
 
3.34
5.46
8.74
8
 
 
1m
3m
6m
1y
 
Sentiment
 

  Login to display

Rewards

Rewards

 Upgraded on attractively valued

Risk Analysis

Risk Analysis

 Analysts lowered price target

 
 
 
 
Street Consensus
 
Buy
Opinion
Trend
Score
Potential
Score
 
50%
0%
0%
On Track
On Track
On Track
 
36%
45%
Positive
Negative
8 out of 22
events present
10 out of 22
events present
 

Street Opinion

Street view is unimpressive and have negative views on the near-term outlook

 
 
Analysts Opinion
Hover the category for more information
 
 
Earnings ×
 

Earnings

2.67
 

TrendSpott

Reported a weak earnings

TrendSpott

Earnings decline YoY

TrendSpott

Above analyst estimates

 
 
Rating ×
 

Rating

3.00
 

TrendSpott

Upgraded on attractively valued

 
Momentum ×
 

Momentum

2.50
 

TrendSpott

Price value has negative momentum

 
Activity ×
 

Activity

3.30
 
 
Future ×
 

Future

1.00
 

TrendSpott

Analysts lowered price target

 
 

Analysts Opinion

Analysts opinion is negative but has improved from the past 3 months

 
 
 
Events Rating
 
Very Bullish
Bullish
Neutral
Bearish
Very Bearish
 
 
Events Calendar
Hover for information
 
February
 
S
M
T
W
T
F
S
 
 
 
March
S
M
T
W
T
F
S
 
 
 
 
Highlights
Last
Modify
Closing
Price
%
Change
 
Strong Earnings
3 Weeks Ago
3.67
+1.38%
 
Weak Earnings
2 Month Ago
3.67
+6.07%
 
Price Target Lowered
2 Month Ago
3.34
-53.16%
 
Upgrade
2 Month Ago
7.46
+11.18%
 
Investors Activity
3 Month Ago
5.99
+5.09%
 
 
 
TrendSpott

Get all the pieces of the puzzle on important data activity before the major news sources break the story and find out what happening right now and what could happen in the future

FIND US ON

TrendSpott on Twitter TrendSpott on YouTube TrendSpott on stocktwits TrendSpott Rss

 

Receive our daily GTHX Alerts

Enter your email to receive daily alerts

 
Home

Leading Gainers

Upgrades

Downgrades

Top Leaders

Categories

Ipo's

Dividend

Option Activity

Insiders Activity

Institutional Holdings

Tags

New Products

FDA Approvals

Agreements

Financial Reports

 
 

Disclaimer: The Score performance whether actual or indicated by historical tests of strategies, is no guarantee of future performance or success. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The Readiness Indicators, Sentiment Indicators and total score are calculated by the retroactive application of a model constructed on the basis of historical data and based on assumptions integral to the model which may or may not be testable and are subject to losses. Active trading is generally not appropriate for someone of limited resources, limited invesment or trading experience, or low-risk tolerance. Your capital may be at risk.

Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by TrendSpott including any of their affiliates ("TS").

This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.

 
 
 
 
 

Top Headlines